Drugs@FDA document

WIDAPLIK Letter · NDA 219423 SUPPL-2

Drugs@FDA document · AZURITY · Jun 16, 2026

Key facts

Drug name WIDAPLIK
Document type Letter
Application NDA219423
Submission SUPPL-2
Company AZURITY
Document date Jun 16, 2026
FDA document accessdata.fda.gov

At a glance

  • Labeling-Container/Carton Labels, Labeling-Package Insert Document categories
  • 1–9 Documents for this application

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Drugs@FDA documents

Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.

Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date:

Browse all Drugs@FDA documents